pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4280 |
Genomic Coordinates | chr5: 87114879 - 87114954 |
Description | Homo sapiens miR-4280 stem-loop |
Comment | None |
RNA Secondary Structure | ![]() |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4280 | ||||||||||||||||||
Sequence | 11| GAGUGUAGUUCUGAGCAGAGC |31 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | SOLiD | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | SP4 | ||||||||||||||||||||
Synonyms | HF1B, SPR-1 | ||||||||||||||||||||
Description | Sp4 transcription factor | ||||||||||||||||||||
Transcript | NM_003112 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on SP4 | |||||||||||||||||||||
3'UTR of SP4 (miRNA target sites are highlighted) |
>SP4|NM_003112|3'UTR 1 AAAGTTATTTATAACAGAGACCTCTAGTGCTGCACTTGTTTACACACCTTTGAAAATCTGGAAATGGGCTGGTCAAGTGG 81 ATTACAGAGTAGGAAATTATGTTTTCATTCTTGGCTTCTTTAAGTATTCCAGGGTTTGGGGTCAACACGTGAAGTGTTGA 161 ATTTTAAAAAATACAAAAAGCAGACTGATGTACTGGAAACAGAAAAGTATTTCCTCCATACTATAAGTTGTAGTTGTTTG 241 GAAATATATCACATAACCTTTATACAGAATCTTCCCATCTCTTAATATCATGTGTTAACATGTTTAAAAAGACCTTAGTA 321 GTTTGCAGGCTGGACCTTAATTGGACTTATTTTCTTTGAAAGTACTTTGTTATAAATTCAGTCAGTAATAATTTACGTGT 401 ATTCTTTTTCTCTATAGCACAGAAAACAGATAGTTAACTGATGATAGGGATAATACTGTATTTCCTTAGCTTGATTTTTG 481 GAAAATCAACCGAAAATAGTTTGGCCGTCTTTTCTAAATGTTAGAAATTCTTCAACAGTTGAATTAGGTAAGTTCCAAAA 561 CAGTAATCTGAGATGCATCTCAGATCTTTATTACCACTACATTATAGTAGTGTGTATGCAGACAATCAGTGAAGTCCAAT 641 TACTTTCTCCATTTGGAGACACAAGAGGAACATAGAGTTAAATCTTAGGTTAAATTTTAGGTTGACACCTTAGGAAAATG 721 CTGGGAAAAAAATGGTTAAAACAAAACTCATCATAGCTTCAGAAAAATAAAATGAGGCATCTTAACATGCAATGTTCTAA 801 AGTTAGGATTGATTATATTCCTAACCCTAGGTTGAACCACAAAATTTCATTTAAAATGTTTATATTTGGAAATATTTGCA 881 TAGAGTGTAAATTGTTCTGTAGTTTCATATTTTGTAAATATGAGTTATGTTGACAATGTGCAGAATTCTTTATGCTTTGA 961 TGTGGTAGCCAAAGAAAGAATTACACTTTTTTCCAAGGCCAGCAGAAAATTCTCTTTTAACTACATTGTAATTCTTGTTT 1041 TCCTCTACTAAAAATTGGCCAGTCCCATTTTATTTCTAGTGCTATGTAAGAAGGTAATTAGGAATTATAACACAGTAATG 1121 TTTTTATGTTACATCAATAACTGAATTTTCCCTAAAAATTAGCCTAATATATAATAGATATATTATGAAGCAAAACTTTT 1201 ATTTTTGAAAAGGCAGAATAATTTTCAGTGAAGTAAGTGACTAAAGAAAAAAACTATATTATTGTTTATGCAAGGGTCTT 1281 ACAGGAAAGGGTCTTTTTTTTTTTTTTTTTGAGATGGAGTCTCGCTCTCTTGCCCAGGCTGGAGTGCAATGGCACGATCT 1361 CAGCTTACTGCAACCGCCGCCTCCCAGGTTCAAGCGATTCTCCTGTCTTAGCCTCCTGAGTAGCTGGGATTAACAGGCGC 1441 CTGCCACCATGCCTGGCTAATTTTTGTATTTTTAGTAGAGACAGGGTTTCGCCATGTTGGCCAGGCTGGTTTCAAACTCC 1521 TGACCTCAGGTGATCTGCCCACCTCGGCCTCCCAGAGTGCTGGGATTACAGGCATGAGCCACCATGCCCGGCTAGGAAAG 1601 GGTCTTACTAGGAAAGATGGCCAAAAGTTTCATATGAAAAAAATTGGATTATAAACCAGTAACTTAAATATTAATAAGGA 1681 TATTTTATGTTTTAAAAAAGTATTTACACAGAATCATAATCAGTGAAATTGACCATTTGAAAACTAAAAGTTTTTACCTA 1761 CCTGCTCAATTTATTAACATCATTGCTTTGGGGACTGTTTGAATATAGGTACGTGTTTTCTTGTGCATTCTCTATAATTT 1841 CAGGAAAAGTACTAATGCGAATTCTCTTCCAAAATTGTGATGTTTCTTGTATTTTTGATGAAGGAGAAATACTGTAATGA 1921 TCACTGTTTACACTATGTACACTTTAGGCCAGCCCTTTGTAGCGTTATATAAAACTGAAGGTCTTTTGTGCTTTCAGTTT 2001 GTATAAAAAAGCTTTGAGATTAAAGGAAAAAAAAAATTTTTACACTGTGGTTATAAATTTCAAGTTTCTTAAAGCTTTTG 2081 TAGACTTGTAACAGAGTCTTTAAATTTAAGTTGGATTTTGTAAATTGTTTTGTATATTTTATTTAATGTACTCTTAACAA 2161 CTGATGTATCTGGCTTTAAAACATCAGAATTGGTTTGTTGTTTTGTTTGGTACAGAGGAGCATTTGGTAGTGTTCATTTT 2241 AATTTTATTATATAGGAGCTGAAACATCAAATATATATTTTATCTATCATTATGCTACACAATCAGTGCTATAAATTTTT 2321 TTATGCAAAGAAACTTTCTTAATGTTTTAATCATGTTTCCTCAGAGTGACACTTTTTGTTGTTGTTAATACCAAGTATGA 2401 ACACTCTGCATCATTATTCCATGAACCAGTTCTAATGCAAACCTATGTATGTCCATTAGAAATGGAAGTTATTTTTTAAT 2481 CAACAATGAGGCCTATTATAAATTTATCAGATGAATCTAGATAGCTTTATAGCATATAAAATATGTTAATTTGTGTTAGC 2561 AGGTGCACATTTCACCACTGAAATTAGAAATATTTTGACAGTCTGTTCTGCATACCATTCTGAGTCTACTTTTCTGTCTT 2641 TAGAAGAATCGTAAATTTCAGTGTCCTTTATTTGACTCAGTGGGATATAGCTGTTATAAGTAATAGGGCACAGATGTGCA 2721 GTAGAGTCTTGTTTAATGGCATTTCACTGTTCATTCCCTTTACCACCGTTATAAAACTTTTCTTTATTGTAATTATCAGT 2801 GCAAAGCTATGTATTTATCATGGTAAAACTCCAGTGTTAGAATAGTTTTTTCTTACAGTATACTTTCTTTGGTTAGGTTT 2881 GTGTATGTGTTGCTGATTACATTAGAACTTGATGTTAAGTCATTTATCACACTCTCATGAGAGCAGTAATAAAAGTGTGT 2961 AATCTAGGAGAAAAAGTTAATTTGTCAAACTTAGATAAGCATGATGTTTAGGTCCTATTTTTCAATTTTATAACTGTTTT 3041 ATTGCAACAATATTTGTATTTAAGTCTCCATTTTAATGCCTTGTGGTGTTTTTTTATGCATGTCACTAAGTTGTCATCCC 3121 ACATAAATTGATGTGCAGCATAGGGTATTAAATCTACATAATGATTTTAAAACAGAAATAGTTGATGGTAAAATGTAAAT 3201 GTTTTGCAAAAATTCCTTATAAAAAGTTTTGTAGTAACATTTCACTTGTAAATTTTTTTTGTAAAAAAAAAAAAATGAAA 3281 AAAAAAGATGAATCCAGAAAAAAACCTGTTTCCCATATTCTAGAATTTAGACAATTATTCTGCCAGCAAAGCCTCTGGGG 3361 CTGTAATTGACATTTTTACAGTGCTGATTTGTATAAAATTTGTTTTTTGTGGATTTGGAAATAAAATCATGTACAAGTTG 3441 TTGCCTGCAATAACAATTGCAAGTAACCTATTAAAAATTCCCTTGAGTTTAACATGTTTCATTTAATTATGTATACTATA 3521 AAGCAGCAATAAATTATTTGAACTATCAACCTAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM545214. RNA binding protein: AGO3. Condition:Control
PAR-CLIP data was present in GSM545216. RNA binding protein: AGO2. Condition:miR-124 transfection
... - Hafner M; Landthaler M; Burger L; Khorshid et al., 2010, Cell. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hafner M; Landthaler M; Burger L; Khorshid et al. - Cell, 2010
RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
LinkOut: [PMID: 20371350]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 6671.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714644. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 6671.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065670. RNA binding protein: AGO2. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_003112 | 3UTR | CUUCCAAAAUUGUGAUGUUUCUUGUAUUUUUGAUGAAGGAGAAAUACUGUAAUGAUCACUGUUUACACUAUGUACACUUUAGGCCAGCCCUUUGUAGCGUUAUAUAAAACUGAAGGUCUUUUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903834 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_b |
Location of target site | NM_003112 | 3UTR | CACUGUUUACACUAUGUACACUUUAGGCCAGCCCUUUGUAGCGUUAUAUAAAACUGAAGGUCUUUUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_003112 | 3UTR | GAUCACUGUUUACACUAUGUACACUUUAGGCCAGCCCUUUGUAGCGUUAUAUAAAACUGAAGGUCUUUUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_003112 | 3UTR | UUUACACUAUGUACACUUUAGGCCAGCCCUUUGUAGCGUUAUAUAAAACUGAAGGUCUUUUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_003112 | 3UTR | UUGUGAUGUUUCUUGUAUUUUUGAUGAAGGAGAAAUACUGUAAUGAUCACUGUUUACACUAUGUACACUUUAGGCCAGCCCUUUGUAGCGUUAUAUAAAACUGAAGGUCUUUUGUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM545214 | |
---|---|
Method / RBP | PAR-CLIP / AGO3 |
Cell line / Condition | HEK293 / Control |
Location of target site | ENST00000222584.3 | 3UTR | UUUACACUAUGUACACUUUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM545216 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / miR-124 transfection |
Location of target site | ENST00000222584.3 | 3UTR | UUUACACUAUGUACACUUUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 20371350 / GSE21578 |
CLIP-seq Viewer | Link |
CLIP-seq Support 8 for dataset GSM714644 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repA |
Location of target site | ENST00000222584.3 | 3UTR | UUUACACUAUGUACACUUUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 9 for dataset GSM1065670 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / 4-thiouridine, 3_ML_LG |
Location of target site | ENST00000222584.3 | 3UTR | UUUACACUAUGUACACUUUAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
67 hsa-miR-4280 Target Genes:
Functional analysis:
ID![]() |
Target | Description | Validation methods |
![]() |
![]() |
|||||||
Strong evidence | Less strong evidence | |||||||||||
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|||||
MIRT065612 | DAZAP2 | DAZ associated protein 2 | ![]() |
![]() |
2 | 10 | ||||||
MIRT084985 | BACH1 | BTB domain and CNC homolog 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT088053 | UBXN2A | UBX domain protein 2A | ![]() |
![]() |
2 | 4 | ||||||
MIRT097327 | SCAMP1 | secretory carrier membrane protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT099148 | MYLIP | myosin regulatory light chain interacting protein | ![]() |
![]() |
2 | 12 | ||||||
MIRT127042 | FAM208B | family with sequence similarity 208 member B | ![]() |
![]() |
2 | 4 | ||||||
MIRT140479 | BNIP2 | BCL2 interacting protein 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT154889 | GNAS | GNAS complex locus | ![]() |
![]() |
2 | 4 | ||||||
MIRT187983 | MBD6 | methyl-CpG binding domain protein 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT190440 | EIF5 | eukaryotic translation initiation factor 5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT240673 | GAPVD1 | GTPase activating protein and VPS9 domains 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT295049 | EVI5L | ecotropic viral integration site 5 like | ![]() |
![]() |
2 | 2 | ||||||
MIRT324749 | ACER2 | alkaline ceramidase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT366075 | FAM127A | retrotransposon Gag like 8C | ![]() |
![]() |
2 | 4 | ||||||
MIRT442625 | LOX | lysyl oxidase | ![]() |
![]() |
2 | 2 | ||||||
MIRT445224 | TYRP1 | tyrosinase related protein 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT448967 | CCNT2 | cyclin T2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT450137 | PFN4 | profilin family member 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT464350 | USP46 | ubiquitin specific peptidase 46 | ![]() |
![]() |
2 | 2 | ||||||
MIRT470460 | PPP1R15B | protein phosphatase 1 regulatory subunit 15B | ![]() |
![]() |
2 | 2 | ||||||
MIRT473691 | MAPK8 | mitogen-activated protein kinase 8 | ![]() |
![]() |
2 | 4 | ||||||
MIRT480188 | CALM2 | calmodulin 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT486355 | PCBD2 | pterin-4 alpha-carbinolamine dehydratase 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT486708 | TROVE2 | TROVE domain family member 2 | ![]() |
![]() |
2 | 4 | ||||||
MIRT488337 | SCD | stearoyl-CoA desaturase | ![]() |
![]() |
2 | 2 | ||||||
MIRT489322 | PEX26 | peroxisomal biogenesis factor 26 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491791 | ZNF24 | zinc finger protein 24 | ![]() |
![]() |
2 | 2 | ||||||
MIRT491970 | USP37 | ubiquitin specific peptidase 37 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492029 | TWF1 | twinfilin actin binding protein 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT492063 | TMEM245 | transmembrane protein 245 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492247 | SLC39A9 | solute carrier family 39 member 9 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492254 | SLC35F5 | solute carrier family 35 member F5 | ![]() |
![]() |
2 | 2 | ||||||
MIRT492592 | PPIL4 | peptidylprolyl isomerase like 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493436 | KAT7 | lysine acetyltransferase 7 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493470 | IPMK | inositol polyphosphate multikinase | ![]() |
![]() |
2 | 2 | ||||||
MIRT493639 | HECTD1 | HECT domain E3 ubiquitin protein ligase 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT493919 | FAM127B | retrotransposon Gag like 8A | ![]() |
![]() |
2 | 4 | ||||||
MIRT494639 | ARNTL | aryl hydrocarbon receptor nuclear translocator like | ![]() |
![]() |
2 | 2 | ||||||
MIRT500032 | ABCF2 | ATP binding cassette subfamily F member 2 | ![]() |
![]() |
2 | 8 | ||||||
MIRT504589 | ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | ![]() |
![]() |
2 | 4 | ||||||
MIRT505535 | SP4 | Sp4 transcription factor | ![]() |
![]() |
2 | 6 | ||||||
MIRT507539 | DNAJB6 | DnaJ heat shock protein family (Hsp40) member B6 | ![]() |
![]() |
2 | 6 | ||||||
MIRT508846 | TMCO1 | transmembrane and coiled-coil domains 1 | ![]() |
![]() |
2 | 4 | ||||||
MIRT510488 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | ![]() |
![]() |
2 | 2 | ||||||
MIRT511402 | IFNAR2 | interferon alpha and beta receptor subunit 2 | ![]() |
![]() |
2 | 6 | ||||||
MIRT523252 | HIST1H2AH | histone cluster 1 H2A family member h | ![]() |
![]() |
2 | 2 | ||||||
MIRT525939 | C11orf74 | chromosome 11 open reading frame 74 | ![]() |
![]() |
2 | 2 | ||||||
MIRT531453 | HSD17B12 | hydroxysteroid 17-beta dehydrogenase 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT533317 | UNKL | unkempt family like zinc finger | ![]() |
![]() |
2 | 2 | ||||||
MIRT541034 | STRBP | spermatid perinuclear RNA binding protein | ![]() |
![]() |
2 | 8 | ||||||
MIRT546734 | RNF217 | ring finger protein 217 | ![]() |
![]() |
2 | 2 | ||||||
MIRT555125 | PTPRJ | protein tyrosine phosphatase, receptor type J | ![]() |
![]() |
2 | 2 | ||||||
MIRT556105 | MOAP1 | modulator of apoptosis 1 | ![]() |
![]() |
2 | 2 | ||||||
MIRT560205 | AK4 | adenylate kinase 4 | ![]() |
![]() |
2 | 2 | ||||||
MIRT561087 | LLPH | LLP homolog, long-term synaptic facilitation | ![]() |
![]() |
2 | 2 | ||||||
MIRT566967 | LBR | lamin B receptor | ![]() |
![]() |
2 | 2 | ||||||
MIRT567344 | H3F3B | H3 histone family member 3B | ![]() |
![]() |
2 | 2 | ||||||
MIRT567863 | DCAF12 | DDB1 and CUL4 associated factor 12 | ![]() |
![]() |
2 | 2 | ||||||
MIRT574449 | SCML2 | Scm polycomb group protein like 2 | ![]() |
![]() |
2 | 2 | ||||||
MIRT575700 | Map1b | microtubule-associated protein 1B | ![]() |
![]() |
2 | 2 | ||||||
MIRT651432 | YIPF6 | Yip1 domain family member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT659728 | CCDC93 | coiled-coil domain containing 93 | ![]() |
![]() |
2 | 2 | ||||||
MIRT686937 | SFT2D3 | SFT2 domain containing 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT699385 | SLC30A6 | solute carrier family 30 member 6 | ![]() |
![]() |
2 | 2 | ||||||
MIRT710287 | CSNK1G3 | casein kinase 1 gamma 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT715123 | PANK3 | pantothenate kinase 3 | ![]() |
![]() |
2 | 2 | ||||||
MIRT721847 | VLDLR | very low density lipoprotein receptor | ![]() |
![]() |
2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|